| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
REVIEW SERIES |
Correspondence to:
Correspondence to:
E F M Wouters, Department of Pulmonology, University Hospital Maastricht, 6202 AZ Maastricht, The Netherlands
ewo{at}slon.azm.nl
ABSTRACT
The role of body cell mass wasting, muscle wasting, and changes in muscle metabolism in the pathogenesis of chronic obstructive pulmonary disease is reviewed.
Keywords: chronic obstructive pulmonary disease; muscle wasting; body cell mass
This article has been cited by other articles:
|
|
 |
|
  T. Raupach, F. Bahr, P. Herrmann, L. Luethje, K. Heusser, G. Hasenfuss, L. Bernardi, and S. Andreas Slow breathing reduces sympathoexcitation in COPD Eur. Respir. J., August 1, 2008; 32(2): 387 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Clini and N. Ambrosino Nonpharmacological treatment and relief of symptoms in COPD Eur. Respir. J., July 1, 2008; 32(1): 218 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Scichilone, G. Paglino, S. Battaglia, L. Martino, A. Interrante, and V. Bellia The mini nutritional assessment is associated with the perception of dyspnoea in older subjects with advanced COPD Age Ageing, March 1, 2008; 37(2): 214 - 217. [Full Text] [PDF]
|
|
|
|
 |
|
 D. D Sin and W D. Reid Is inflammation good, bad or irrelevant for skeletal muscles in COPD? Thorax, February 1, 2008; 63(2): 95 - 96. [Full Text] [PDF]
|
|
|
|
 |
|
 E. F. M. Wouters, K. H. Groenewegen, M. A. Dentener, and J. H. J. Vernooy Systemic Inflammation in Chronic Obstructive Pulmonary Disease: The Role of Exacerbations Proceedings of the ATS, December 1, 2007; 4(8): 626 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ambrosino and R. Goldstein Series on comprehensive management of end-stage COPD Eur. Respir. J., November 1, 2007; 30(5): 828 - 830. [Full Text] [PDF]
|
|
|
|
|
|
A. Agusti Systemic Effects of Chronic Obstructive Pulmonary Disease: What We Know and What We Don't Know (but Should) Proceedings of the ATS, October 1, 2007; 4(7): 522 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Anzueto, S. Sethi, and F. J. Martinez Exacerbations of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, October 1, 2007; 4(7): 554 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Budweiser, R. A. Jorres, T. Riedl, F. Heinemann, A. P. Hitzl, W. Windisch, and M. Pfeifer Predictors of Survival in COPD Patients With Chronic Hypercapnic Respiratory Failure Receiving Noninvasive Home Ventilation Chest, June 1, 2007; 131(6): 1650 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S F P Man, J E Connett, N R Anthonisen, R A Wise, D P Tashkin, and D D Sin C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease Thorax, October 1, 2006; 61(10): 849 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sorhaug, A. Langhammer, H. L. Waldum, K. Hveem, and S. Steinshamn Increased serum levels of chromogranin A in male smokers with airway obstruction Eur. Respir. J., September 1, 2006; 28(3): 542 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. F. M. Wouters The systemic face of airway diseases: the role of C-reactive protein. Eur. Respir. J., May 1, 2006; 27(5): 877 - 879. [Full Text] [PDF]
|
|
|
|
|
|
E. F. M. Wouters Approaches to Improving Health Status in Chronic Obstructive Pulmonary Disease: One or Several? Proceedings of the ATS, May 1, 2006; 3(3): 262 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Similowski, A. Agusti, W. MacNee, and B. Schonhofer The potential impact of anaemia of chronic disease in COPD Eur. Respir. J., February 1, 2006; 27(2): 390 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D D Sin and S F P Man Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax, January 1, 2006; 61(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
|
|
S. I. Rennard and J. A. Stoner Challenges and Opportunities for Combination Therapy in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 391 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Andreas, S. D. Anker, P. D. Scanlon, and V. K. Somers Neurohumoral Activation as a Link to Systemic Manifestations of Chronic Lung Disease Chest, November 1, 2005; 128(5): 3618 - 3624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Couillard and C. Prefaut From muscle disuse to myopathy in COPD: potential contribution of oxidative stress Eur. Respir. J., October 1, 2005; 26(4): 703 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Donaldson, T. A. R. Seemungal, I. S. Patel, A. Bhowmik, T. M. A. Wilkinson, J. R. Hurst, P. K. MacCallum, and J. A. Wedzicha Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD Chest, October 1, 2005; 128(4): 1995 - 2004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chambellan, E. Chailleux, and T. Similowski Prognostic Value of the Hematocrit in Patients With Severe COPD Receiving Long-term Oxygen Therapy Chest, September 1, 2005; 128(3): 1201 - 1208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. P. Man and D. D. Sin Effects of Corticosteroids on Systemic Inflammation in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 78 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Donaldson, T. M. A. Wilkinson, J. R. Hurst, W. R. Perera, and J. A. Wedzicha Exacerbations and Time Spent Outdoors in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 446 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sethi Musculoskeletal Effects of Chronic Obstructive Pulmonary Disease: Prevalent, Linked, but Ignored Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1267 - 1268. [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Rana, M. A. Mittleman, J. Sheikh, F. B. Hu, J. E. Manson, G. A. Colditz, F. E. Speizer, R. G. Barr, and C. A. Camargo Jr Chronic Obstructive Pulmonary Disease, Asthma, and Risk of Type 2 Diabetes in Women Diabetes Care, October 1, 2004; 27(10): 2478 - 2484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Sin, P. Lacy, E. York, and S. F. P. Man Effects of Fluticasone on Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 1, 2004; 170(7): 760 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Divangahi, S. Matecki, R. W. R. Dudley, S. A. Tuck, W. Bao, D. Radzioch, A. S. Comtois, and B. J. Petrof Preferential Diaphragmatic Weakness during Sustained Pseudomonas aeruginosa Lung Infection Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 679 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J A Wedzicha, S L Johnston, and D M Mitchell Annual report October 2002 to September 2003 Thorax, December 1, 2003; 58(12): 1015 - 1017. [Full Text] [PDF]
|
|
|
|
|
|
E-J.D. Oudijk, J-W.J. Lammers, and L. Koenderman Systemic inflammation in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 5S - 13s. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
